How to Get Funded by 7wireVentures: Digital Health VC

7wire Ventures Fund III, L.P. reported $111.02 million on October 15, 2026, and a companion vehicle, 7wire Ventures Fund III-A, L.P., reported $2.62 million. Glen Tullman signed both. Tullman is a co-founder and partner at 7wireVentures, a Chicago venture firm that invests in early-stage healthcare technology, and the filings suggest a new pool of capital for health technology founders.

What the Filings Show and Do Not Show

The filings give amounts and a signer but no description. I could not find a public announcement of a Fund III with its target size, close date or strategy. One third-party directory lists a "Core Fund III" deploying across seed and Series A, but I could not confirm that against a primary source, so this article treats the amounts as what was reported on October 15 and does not say whether they are final.

Reading the Two Filings Together

A main fund and a smaller companion vehicle with an "A" suffix often work as a pair, with the second structured for a different group of investors. Here the companion reported $2.62 million against $111.02 million for the main fund, so the two should be read as one program and not added up as separate raises. The size of the main vehicle sits between the firm's 2021 and 2023 funds, which is consistent with a firm that raises regularly and keeps funds focused, though the filing alone does not confirm that this is a successor to either one.

What Is Known About the Firm

7wireVentures was co-founded by Glen Tullman and Lee Shapiro and focuses on early-stage digital health. In 2021 it announced it had closed a $150 million Connected Consumer Health Fund. In 2023 it closed a $217 million Growth and Opportunity fund, described at the time as its largest, which brought the firm's assets under management to more than $500 million. The firm has backed Livongo, which Teladoc acquired in a deal valued at about $18.5 billion, and NOCD, a virtual therapy company for obsessive-compulsive disorder.

The Person Behind It

Tullman is the former founder and chief executive of Livongo Health and is now chief executive of Transcarent. He is also reported to have a separate venture fund of about $100 million, called 62 Ventures, meant for companies outside the strict digital health focus of 7wire. A partner who has built and sold a health technology company brings operating experience that many investors lack.

What This Means for Founders

For a digital health founder, a firm with fresh capital and an operator at the helm is worth approaching. The pattern across its funds is a move from a single consumer focus toward both early and growth rounds, so the firm can support a company across several financings.

Before you reach out, be ready to explain how your product is paid for. Healthcare buyers include employers, health plans and providers, and investors in this field will ask who writes the check, how long the sales cycle lasts and what evidence shows the product works. A company that sells to employers has a different timeline from one that sells to hospitals, and a clear answer shows that you understand the market.

How to Approach a Specialist Firm

A firm that has backed Livongo and similar companies has seen many pitches in the same field, so generic claims will not stand out. Lead with specifics: the size of the group you serve, the outcome you improve and a number that proves it, such as engagement, savings or clinical results. Name a customer or pilot if you can, and say what you need the capital for. If you are raising a seed round, show the milestones that would justify a Series A.

Ask the partners how they support portfolio companies after investing. A firm with deep health industry relationships can help with introductions to buyers and regulators, which may matter as much as the money. Ask also how the fund reserves capital for later rounds, since digital health companies often need several financings before reaching steady revenue, and understand how a lead investor in your round will think about dilution across those rounds.

Timing Your Approach

Funds that have just filed are usually at the start of their investment period, which is when partners are most active in meeting new companies. If your company is close to raising, reach out in the next few months and have a short deck ready. If you are further away, use the time to collect customer results, because digital health investors weigh evidence of outcomes and renewals more than projections.

The Bigger Picture

On the day 7wire filed, 220 vehicles reported about $47 billion, and venture funds were 52 of those vehicles with only about 1.5% of the dollars. A specialist health fund of this size is small next to the large credit and hedge vehicles filed the same day, yet it is exactly the kind of capital that early health founders need. Look for firms that have opened new vehicles recently, read what they have published, and approach those whose stated focus matches your product.

Browse the AI and machine learning investor directory for more active funds, read the baseline mechanics of a limited partner if the term is new, or explore active capital on AngelLinx @ angellinx.ai/register.

AngelLinx Intelligence | angellinx.ai